Vinblastine
Indications
Hematologic Malignancies
Solid Malignancies
Pharmacology
Metabolism
Administration
Dose Adjustment
Adverse Effects
Hematologic Adverse Effects
Mild Myelosuppression
Pulmonary Adverse Effects
General Comments
- Pulmonary toxicity is mainly observed when vinblastine is used in combination with other chemotherapeutic agents, particularly mitomycin-C
Acute Respiratory Distress Syndrome (ARDS) (see Acute Respiratory Distress Syndrome, [[Acute Respiratory Distress Syndrome]])
Bronchospasm (see Obstructive Lung Disease, [[Obstructive Lung Disease]])
Interstitial Pneumonitis (see Interstitial Lung Disease, [[Interstitial Lung Disease]])
Other Adverse Effects
References